Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1743studies shown
Showing 589-600 of 1,743
Drug study icon
TerminatedNCT00483535

Oral Contraceptive Interaction Study for GW273225

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
BipolarityDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
United Kingdom
Sponsor
GlaxoSmithKline
Condition
Bipolarity
Behavioral study icon
CompletedNCT05963581

Oxford Social Movement Activation Study

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
DepressionBehavioralFrom 18 Years to 24 Years
Countries
United Kingdom
Sponsor
University of Oxford
Condition
Depression
Drug study icon
CompletedNCT01281527

Paliperidone Palmitate Flexible Dosing in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
SchizophreniaDrugOver 18 Years
Countries
France, United Kingdom, Switzerland, ...
Sponsor
Janssen-Cilag International NV
Condition
Schizophrenia
Drug study icon
CompletedNCT01911429

Pediatric Schizophrenia Efficacy and Safety Study

This study is completed in the United States, in France, in the United Kingdom, .... It focuses on schizophrenia.

In United Kingdom
SchizophreniaDrugFrom 13 Years to 17 Years
Countries
United States, France, United Kingdom, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02232529

Pharmacokinetic Study of MIN-101 in Healthy Subjects

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United Kingdom
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
Drug study icon
TerminatedNCT05839509

Phase 2 study of GH001 in Bipolarity type II

This study was terminated in the United Kingdom, in Germany, and in the Netherlands. It is testing Phase 2 Clinical Trial of GH001 for Bipolarity.

In United Kingdom
BipolarityDrugFrom 18 Years to 64 Years
Countries
United Kingdom, Germany, Netherlands
Sponsor
GH Research Ireland Limited
Condition
Bipolarity
Drug study icon
TerminatedNCT05804708

Phase 2 study of GH001 in Postpartum Depression

This study was terminated in the United Kingdom and in the Netherlands. It focuses on depression.

In United Kingdom
DepressionDrugFrom 18 Years to 45 Years
Countries
United Kingdom, Netherlands
Sponsor
GH Research Ireland Limited
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.